Heart failure and cerebral ischemia

Heart failure patients may have impaired cerebral autoregulation and regional blood flow abnormalities. Predisposition to thromboembolic complications occur because of dilated chambers abnormal flow, vessel/chamber lining particles in heart patients. Epidemiological clinical studies document an increased rate failure. Well known/accepted indications oral anticoagulation therapy prevent events are co-existence atrial fibrillation/flutter, intracardiac thrombi a history event. Other than coronary artery disease failure, antiplatelet agents should not be used ischemic stroke. How who treat/prevent event with sinus rhythm is hot topic. Up date, treatment anticoagulant agents-mainly warfarin recently rivaroxaban vs or placebo could meet their primary outcome related morbidity/mortality. In some these studies, decreased strokes were offset by major hemorrhage.